{"id":673236,"date":"2025-06-03T07:01:30","date_gmt":"2025-06-03T04:01:30","guid":{"rendered":"https:\/\/en.buradabiliyorum.com\/elon-musks-neuralink-closes-a-650m-series-e\/"},"modified":"2025-06-03T07:01:30","modified_gmt":"2025-06-03T04:01:30","slug":"elon-musks-neuralink-closes-a-650m-series-e","status":"publish","type":"post","link":"https:\/\/buradabiliyorum.com\/en\/elon-musks-neuralink-closes-a-650m-series-e\/","title":{"rendered":"Elon Musk’s Neuralink closes a $650M Series E"},"content":{"rendered":"
\n

Elon Musk\u2019s brain computer interface startup Neuralink closed a $650 million funding round, the company announced in a blog post<\/a> on Monday. The Series<\/a> E fundraise included investors such as ARK Invest, Founders Fund, Sequoia Capital, and Thrive Capital, among others.<\/p>\n

Neuralink last raised a $280 million Series D funding round in 2023, with an additional $43 million tranche added months later. Since then, Neuralink\u2019s brain chip technology<\/a> has made some significant leaps.<\/p>\n

The company says it has now conducted more human clinical trials, implanting its brain chips in five individuals with severe paralysis. In May, Neuralink received breakthrough device designation<\/a> from the U.S. Food and Drug Administration, a program intended to speed up development, assessment, and review processes for experimental technologies.<\/p>\n

Semafor reported last week that this latest deal values Neuralink at around $9 billion pre-money.<\/p>\n<\/div>\n

If you liked the article, do not forget to share it with your friends. Follow us on\u00a0Google News<\/a><\/span>\u00a0too, click on the star and choose us from your favorites.<\/span><\/strong><\/p><\/blockquote>\n

\n

If you want to read more like this article, you can visit our Technology<\/a><\/span> category.<\/strong><\/p>\n<\/blockquote>\n

Source<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

Elon Musk\u2019s brain computer interface startup Neuralink closed a $650 million funding round, the company announced in a blog post on Monday. The Series E fundraise included investors such as ARK Invest, Founders Fund, Sequoia Capital, and Thrive Capital, among others. Neuralink last raised a $280 million Series D funding round in 2023, with an…<\/p>\n","protected":false},"author":1,"featured_media":673237,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/techcrunch.com\/wp-content\/uploads\/2025\/02\/GettyImages-2198970101.jpg?resize=1200,800","fifu_image_alt":"","footnotes":""},"categories":[18],"tags":[151516,156840,70917,151477],"class_list":["post-673236","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technology","tag-biotech-health","tag-neurlink","tag-startups","tag-venture"],"_links":{"self":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/673236","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/comments?post=673236"}],"version-history":[{"count":0,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/673236\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media\/673237"}],"wp:attachment":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media?parent=673236"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/categories?post=673236"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/tags?post=673236"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}